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Borrelia infection and risk of celiac disease
Armin Alaedini1,2,3*, Benjamin Lebwohl1,2,4, Gary P. Wormser5, Peter H. Green1,2 and Jonas F. Ludvigsson4,6,7*
Abstract
Background: Environmental factors, including infectious agents, are speculated to play a role in the rising
prevalence and the geographic distribution of celiac disease, an autoimmune disorder. In the USA and Sweden
where the regional variation in the frequency of celiac disease has been studied, a similarity with the geographic
distribution of Lyme disease, an emerging multisystemic infection caused by Borrelia burgdorferi spirochetes, has
been found, thus raising the possibility of a link. We aimed to determine if infection with Borrelia contributes to an
increased risk of celiac disease.
Methods: Biopsy reports from all of Sweden’s pathology departments were used to identify 15,769 individuals with
celiac disease. Through linkage to the nationwide Patient Register, we compared the rate of earlier occurrence of
Lyme disease in the patients with celiac disease to that in 78,331 matched controls. To further assess the temporal
relationship between Borrelia infection and celiac disease, we also examined the risk of subsequent Lyme disease in
patients with a diagnosis of celiac disease.
Results: Twenty-five individuals (0.16%) with celiac disease had a prior diagnosis of Lyme disease, whereas 79
(0.5%) had a subsequent diagnosis of Lyme disease. A modest association between Lyme disease and celiac disease
was seen both before (odds ratio, 1.61; 95% confidence interval (CI), 1.06–2.47) and after the diagnosis of celiac
disease (hazard ratio, 1.82; 95% CI, 1.40–2.35), with the risk of disease being highest in the first year of follow-up.
Conclusions: Only a minor fraction of the celiac disease patient population had a prior diagnosis of Lyme disease.
The similar association between Lyme disease and celiac disease both before and after the diagnosis of celiac
disease is strongly suggestive of surveillance bias as a likely contributor. Taken together, the data indicate that
Borrelia infection is not a substantive risk factor in the development of celiac disease.
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Background
Celiac disease is an autoimmune enteropathy with genetic,
environmental, and immunologic components [1]. It is
characterized by an aberrant immune response to ingested
wheat gluten and related proteins of rye and barley that
leads to inflammation and tissue damage in the small intes-
tine [2]. Celiac disease is strongly associated with genes for
the specific class II human leukocyte antigens (HLAs) DQ2
and DQ8 [3]. It is estimated to affect close to 1% of the
American population [4, 5], compared with up to 2–3% in
Sweden and Finland [6, 7]. Because it can occur at any age,
factors other than genes and gluten ingestion are believed
to play a significant role in disease onset. In addition, recent
studies point to an increasing prevalence of celiac disease
in the USA and Europe within the past few decades [8–10],
underscoring the potential contribution of environmental
factors. Among these, exposure to infectious agents, par-
ticularly those affecting the gastrointestinal tract, and the
risk of celiac disease have been examined in several studies
[11–14], but the results are not consistent, and a firm con-
clusion has not been reached [15, 16]. A recent study dem-
onstrates that the inflammation caused by reovirus
infection can contribute to the development of auto-
immunity in celiac disease through the suppression of per-
ipheral regulatory T cell conversion [17].
Lyme disease, also known as Lyme borreliosis, is caused
by the Borrelia burgdorferi sensu lato spirochetal bacteria.
B. burgdorferi sensu stricto is the primary cause of Lyme
borreliosis in the USA, whereas B. afzelii, B. garinii, and B.
burgdorferi are the causative agents in Europe [18]. Lyme
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disease is currently the most common vector-borne infec-
tion in the USA and Europe, where its incidence has been
rapidly increasing in recent years [19, 20]. Although anti-
biotic therapy resolves clinical symptoms in the majority of
cases, a fraction of patients will develop persistent joint in-
flammation that does not respond to antibiotic treatment
[21]. The antibiotic-refractory Lyme arthritis is believed to
be the result of Borrelia infection-induced autoimmunity
and is associated with autoantibodies [22, 23], an acute-
phase inflammatory response [24], and the class II major
histocompatibility complex (MHC) molecule HLA-DR4
[25]. The condition often responds to immunomodulatory
or anti-inflammatory agents [26].
The potential for the contribution of infection with Bor-
relia to a later onset of celiac disease or gluten sensitivity
has recently garnered attention and is discussed in various
Internet forums [27–29]. In addition, recent studies from
the USA and Sweden examining the regional variation in
the frequency of celiac disease have demonstrated some
similarity with the geographic distribution of Lyme dis-
ease. In the USA, celiac disease has been found to be most
prevalent in the Northeast and the Midwest regions [30],
where the great majority of cases of B. burgdorferi infec-
tion also occur [19]. In Sweden, the highest incidence of
celiac disease has been associated with the southern re-
gion [31], where Lyme disease is endemic [32]. Despite
the similar pattern of geographic distribution and the pub-
licized conjecture regarding a potential link between celiac
disease and Lyme borreliosis, studies to assess such an
association are lacking. In this study, we use a population-
based approach to examine whether infection with Borre-
lia increases the risk of celiac disease.
Methods
Study population
For this study, celiac disease was defined as a patient’s hav-
ing villous atrophy (Marsh 3 histopathology grade) [33].
Earlier validation found that 96–100% of all gastroenterolo-
gists and pediatricians in Sweden performed a biopsy before
celiac disease diagnosis during the study period and that in
cases of reported villous atrophy, a comorbidity other than
celiac disease was rare [34]. Data on villous atrophy were
obtained from computerized biopsy reports from all of Swe-
den’s 28 pathology departments. Biopsies had been carried
out in 1969–2008, while the data collection took place in
2006–2008. Biopsy data included personal identity number,
date of biopsy, topography (duodenum and jejunum), and
morphology. The biopsy reports were on average based on
three tissue specimens [35], which would be expected to de-
tect 95% of all celiac disease cases [36]. Biopsy was required
for celiac disease diagnosis throughout the study period. Bi-
opsy data were linked through the unique personal identity
number [37] to inpatient and hospital-based outpatient data
with respect to a previous diagnosis of Lyme disease.
Exposure to Borrelia infection was defined as having the
relevant International Classification of Diseases (ICD)
code for Lyme disease in the Swedish Patient Register
(ICD-10: A69.2) [38]. The registry began in 1964 and be-
came nationwide in 1987. The Patient Register was limited
to inpatient data until 2000, but since 2001 it has also con-
tained hospital-based outpatient data. The ICD code for
Lyme disease was introduced in 1997.
We matched each individual with celiac disease with up
to five controls for sex, age, county, and calendar year. Con-
trols were selected by the Statistics Sweden government
agency, using the Swedish Total Population Register [39].
Since information regarding diagnosis of Lyme disease
was available starting on January 1, 1997, we only included
study participants on or after January 1, 1998 (i.e., so that
all participants had the potential to be exposed to a Lyme
disease diagnosis for at least one year). This resulted in
15,769 individuals with celiac disease and 78,331 matched
controls.
Statistical analysis
We used conditional logistic regression to calculate odds
ratios (ORs) for later celiac disease among individuals
with Lyme disease. The conditional approach means that
each individual with celiac disease was only compared
with his/her matched control (within a stratum). In this
way, age, sex, county, and calendar year do not affect
risk estimates. Furthermore, we examined the risk of ce-
liac disease according to the time since the diagnosis of
Lyme disease (<1, 1–4.99, and ≥ 5 years). We also ad-
justed for country of birth (Nordic vs. not Nordic) and
educational level using four a priori-defined categories
[40]. Four percent of study participants lacked data on
educational level and were fitted into a separate fifth cat-
egory in the multivariate analysis.
To assess the temporal relationship between celiac dis-
ease and Lyme disease, we also examined the risk of
later Lyme disease in patients with an initial diagnosis of
celiac disease. This analysis was restricted to 15,742 indi-
viduals without a prior Lyme disease diagnosis at first bi-
opsy with celiac disease and 78,230 matched controls.
Cox regression was used to estimate the hazard ratio
(HR). The follow-up period continued for each celiac
disease patient and control until the first Lyme disease
diagnosis, death, emigration, or December 31, 2009.
We used SPSS 22 (SPSS, Inc.) for all analyses. The OR
and HR findings with 95% confidence intervals that did not
overlap with 1.0 were regarded as statistically significant.
Ethics
This study was approved by the Ethics Review Board of
Stockholm, Sweden. According to the board’s decision,
no study participant was contacted, and the study was
strictly register-based [41].
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Results
The demographic characteristics of the study partici-
pants are shown in Table 1. The median year of study
entry was 2002, and the median age at celiac disease
diagnosis (and corresponding age in matched controls)
was 32 years (range 0–95).
Twenty-five (0.16%) individuals with celiac disease and
73 (0.09%) controls had a record of earlier Lyme disease
(OR, 1.61; 95% CI, 1.06–2.47) (Table 1). Adjustment for
the level of education and Nordic origin did not substan-
tially alter the risk (adjusted OR, 1.58; 95% CI, 1.03–2.41).
The OR was highest in the first year after Lyme disease
diagnosis (OR, 1.87; 95% CI, 0.87–4.00) but remained
positive between 1 and 5 years (OR, 1.48; 95% CI, 0.84–
2.60) and thereafter (OR, 1.72; 95% CI, 0.51–5.81). ORs
for celiac disease were similar in men (OR, 1.64; 95% CI,
0.81–3.32) and women (OR, 1.60; 95% CI, 0.94–2.72) (P
for interaction, 0.962).
In the prospective analysis, we found that 79 individ-
uals with celiac disease (0.50%) and 215 controls (0.27%)
had a record of later Lyme disease (HR, 1.82; 95% CI,
1.40–2.35) (Table 1). Adjustment for the level of educa-
tion and Nordic origin had no substantial effect (ad-
justed HR, 1.82; 95% CI, 1.40–2.37). The risk of Lyme
disease was highest in the first year of follow-up (HR,
2.18; 95% CI, 1.07–4.44) but remained significantly in-
creased between 1 and 5 years after celiac disease diag-
nosis (HR, 1.97; 95% CI, 1.41–2.77), and positive
thereafter (HR, 1.44; 95% CI, 0.88–2.34). HRs for Lyme
disease were not significantly different in men (HR, 2.39;
95% CI, 1.71–3.56) and women (HR, 1.51; 95% CI, 1.08–
2.133) (P for interaction, 0.134). The relative risk in the
prospective analysis was not significantly different from
that in the main analysis.
Discussion
The strengths of this study are its nationwide population-
based design and high statistical power. The prevalence of
celiac disease in Sweden is among the highest in the world
[6], making the setting of this study particularly relevant.
Furthermore, the majority of the Swedish population lives
in areas where Lyme disease is endemic [32]. Because
Lyme borreliosis is not a notifiable infection in Europe, ac-
curate estimates of its current incidence in Sweden are
not available. However, a recent study found a mean an-
nual incidence of 464 cases of erythema migrans (a skin
lesion indicative of the early stage of Lyme disease) per
100,000 inhabitants in southeastern Sweden between 1997
and 2002, with a sharp increase in the rate being observed
during the analyzed period [20]. In neighboring Norway, a
recent study of anti-B. burgdorferi IgG seroprevalence (in-
dicative of possible ongoing or past episode of Lyme dis-
ease) reported a rate of about 4% [42].
Infectious agents have been linked to the pathogenesis of
a number of autoimmune diseases, with one or more
mechanisms, such as molecular mimicry, epitope spread-
ing, bystander activation, and suppression of regulatory T
cell function, being implicated [43, 44]. In this study, we
found a modest association between celiac disease and a
prior record of Lyme borreliosis. However, we also found
celiac disease to be similarly associated with a subsequent
occurrence of the infection. Furthermore, both associations
Table 1 Characteristics of patients with celiac disease and matched controls
Characteristic Main analysisa Prospective analysisb
Matched controls Celiac disease Matched controls Celiac disease
No. of participants 78,331 15,769 78,230b 15,742b
Sex
Male, no. (%) 28,934 (36.9) 5837 (37.0) 28,890 (36.9) 5826 (37.0)
Female, no. (%) 49,397 (63.1) 9932 (63.0) 49,340 (63.1) 9916 (63.0)
Agec
≤ 19 years, no. (%) 29,510 (37.7) 5917 (37.5) 29,455 (37.7) 5900 (37.5)
20–39 years, no. (%) 15,746 (20.1) 3167 (20.1) 15,738 (20.1) 3167 (20.1)
40–59 years, no. (%) 17,245 (22.0) 3464 (22.0) 17,226 (22.0) 3460 (22.0)
≥ 60 years, no. (%) 15,830 (20.2) 3221 (20.4) 15,811 (20.2) 3215 (20.4)
Calendar periodc
1998–2002, no. (%) 39,492 (50.4) 7956 (50.5) 39,476 (50.5) 7952 (50.5)
2003–2008, no. (%) 38,839 (49.6) 7813 (49.5) 38,754 (49.5) 7790 (49.5)
Lyme disease, no. (%) 73 (0.09) 25 (0.16) 215 (0.27) 79 (0.50)
aTo assess the risk of celiac disease following a diagnosis of Lyme disease
bTo assess the risk of later Lyme disease in patients with a diagnosis of celiac disease. We excluded patients with an earlier diagnosis of Lyme disease. In addition,
two celiac disease patients with potential data irregularity were excluded
cAt the time of celiac disease diagnosis
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were strongest in the first year after diagnosis. As such, the
observed modest association between celiac disease and
Lyme disease is almost certainly due to surveillance bias,
driven by the possibility that physicians would be more
likely to investigate a patient presenting with Borrelia infec-
tion for markers of celiac disease (and vice versa). Given
that there is some overlap between the systemic symptoms
of Lyme disease and celiac disease, it is reasonable to as-
sume that such surveillance bias would have increased the
probability of celiac disease diagnosis in this study.
We acknowledge that patients with celiac disease may be
different from controls in a number of ways that have not
been measured. Though our cases were matched to con-
trols by age, sex, county, and calendar year, there could be
differences between cases and controls in relationship to
both celiac disease and Lyme borreliosis which may con-
tribute to the observed results. Therefore, while strongly
suggestive of surveillance bias as the likely source for the
association, other components, such as shared genetic, en-
vironmental, or other factors between celiac disease and
Lyme disease might be potential additional contributors.
For example, a variable previously found to be associated
with Lyme borreliosis and celiac disease is income [45, 46].
Furthermore, it is important to note that the results and
conclusions of this study cannot be extrapolated to forms
of gluten sensitivity other than celiac disease.
Conclusions
In summary, we found that, despite the high rates of oc-
currence of both celiac disease and Lyme disease in the
population for this study, only a minor fraction of the
celiac disease patients had an earlier record of Lyme dis-
ease. Furthermore, the modest relationship between
Lyme disease and celiac disease both before and after
the diagnosis of celiac disease points to surveillance bias
or shared risk factors as the likely contributors. Taken
together, our data argue against a causal association of
Borrelia infection with celiac disease.
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